Nano-Enhanced Wound Dressing with Galvanic Ion Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current wound dressings lack effective means to enhance wound healing rates and moisture management, particularly in diverse wound conditions, and often require corrosive chemicals or toxic gases for antimicrobial properties, while prior art does not utilize biodegradable polymer protuberances with medicinal nanoparticles for three-dimensional wound interaction.

Innovation Solution

Nano-enhanced wound dressings featuring patterned biodegradable polymer protuberances with medicinal nanoparticles, such as silver, gold, and zinc, that facilitate galvanic action and controlled release of antimicrobial agents, integrated into a dermal drug delivery platform for enhanced wound healing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional wound dressings are used to absorb wound exudate and prevent bacterial ingress, then the wound can be kept dry and protected, but the wound healing time is prolonged and the dressings lack effective antimicrobial properties without using corrosive chemicals

Engineering Contradiction:
Improveantimicrobial propertyVSAvoidcorrosive chemicals and toxic gases
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the physical state and concentration parameters of metallic ions (silver, zinc, copper) by using controlled release mechanisms from the polymer matrix, achieving effective antimicrobial action without requiring high concentrations that would necessitate corrosive chemicals

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite material system combining biodegradable polymers (PLA, PGA, PLGA, PEG) with metallic nanoparticles and ions, achieving enhanced antimicrobial properties through material composition rather than corrosive chemical treatments

Inventive Principle:
Principle #40Composite materials

2Reliability

If metallic ions are introduced into the wound system for antimicrobial properties, then anti-bacterial and anti-fungal effects are achieved, but the complexity of controlling ion release and maintaining effectiveness increases

Engineering Contradiction:
Improveantimicrobial effectivenessVSAvoidion release control mechanism
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The biodegradable polymer matrix automatically controls the release of metallic ions through its degradation process, eliminating the need for complex external control mechanisms while maintaining sustained antimicrobial effectiveness

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The metallic ions are pre-incorporated into the polymer matrix during manufacturing, allowing for controlled release over time as the polymer degrades, simplifying the overall system design

Inventive Principle:
Principle #10Preliminary action

3Productivity

If the wound is kept dry using traditional dressings, then bacterial ingress is prevented, but the wound healing rate is reduced compared to moist wound environments

Engineering Contradiction:
Improvewound healing rateVSAvoidmoisture management
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent changes the moisture parameter from dry to optimally moist by incorporating hydrophilic biodegradable polymers that retain appropriate moisture levels, thereby accelerating wound healing while maintaining infection protection

Inventive Principle:
Principle #35Parameter changes

4Reliability

If biodegradable polymer protuberances with medicinal nanoparticles are used for three-dimensional wound interaction, then controlled release of antimicrobial agents and galvanic action are achieved, but the manufacturing complexity increases

Engineering Contradiction:
Improvecontrolled release mechanismVSAvoidmanufacturing process
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent applies different properties to different parts of the dressing by incorporating medicinal nanoparticles specifically into the polymer protuberances that contact the wound, achieving localized controlled release where needed most

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent transitions from two-dimensional flat dressings to three-dimensional protuberances with varying heights and geometries, enabling differential cell growth and enhanced contact with the wound surface for improved therapeutic effect

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The nano-enhanced wound dressings promote faster wound healing through increased antimicrobial action, controlled release of medicinal ions, and improved moisture management, addressing the limitations of existing dressings by utilizing biodegradable polymers and galvanic action without corrosive chemicals.

Implementation Method 1

When two or more metals are in contact with a body electrolyte, they can produce galvanic action

Methodology Applied
Scientific EffectGalvanic action:

Implementation Method 2

The polymers can be biodegradable, such as poly-L-lactic acid (PLA), poly-D,L-lactic acid, polyglycolic acid (PGA), poly-L-glycolic acid, and copolymers such as poly-L-lactic-co-glycolic acid (PLGA)

Methodology Applied
Scientific EffectBiodegradation: Decomposition (biological)

Data Source

PatentUS11844671B2Nano-enhanced wound dressing
Publication Date: 2023.12.19 ULSTREETCAREND
  • US11844671B2 patent drawing
  • US11844671B2 patent drawing
  • US11844671B2 patent drawing

AI summary

The present disclosure relates to a dermal drug delivery platform comprising: a primary wound dressing comprising three-dimensional polymer protuberances that extend upward from the dressing surface to engage the wound. The protuberances comprise at least one biocompatible and/or biodegradable polymer and medicinal nanoparticles. In one embodiment, the medicinal nanoparticles may be metallic and provide surface-area-enhanced galvanic action to drive medicinal ions into the wound bed. Various methods of making the disclosed dermal drug delivery platform, as well as three-dimensional methods of treating a wound using the platform are also disclosed.